These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 21394687)

  • 21. A clinical comparison of a bovine-derived xenograft used alone and in combination with enamel matrix derivative for the treatment of periodontal osseous defects in humans.
    Scheyer ET; Velasquez-Plata D; Brunsvold MA; Lasho DJ; Mellonig JT
    J Periodontol; 2002 Apr; 73(4):423-32. PubMed ID: 11990444
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The application of an enamel matrix protein derivative (Emdogain) in regenerative periodontal therapy: a review.
    Sculean A; Schwarz F; Becker J; Brecx M
    Med Princ Pract; 2007; 16(3):167-80. PubMed ID: 17409750
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Favorable periodontal healing of 1-wall infrabony defects after application of calcium phosphate cement wall alone or in combination with enamel matrix derivative: a pilot study with canine mandibles.
    Shirakata Y; Yoshimoto T; Goto H; Yonamine Y; Kadomatsu H; Miyamoto M; Nakamura T; Hayashi C; Izumi Y
    J Periodontol; 2007 May; 78(5):889-98. PubMed ID: 17470023
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Periodontal healing after application of enamel matrix derivative in surgical supra/infrabony periodontal defects in rats with streptozotocin-induced diabetes.
    Shirakata Y; Eliezer M; Nemcovsky CE; Weinreb M; Dard M; Sculean A; Bosshardt DD; Moses O
    J Periodontal Res; 2014 Feb; 49(1):93-101. PubMed ID: 23611485
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Five-year clinical and histologic results following treatment of human intrabony defects with an enamel matrix derivative combined with a natural bone mineral.
    Sculean A; Chiantella GC; Arweiler NB; Becker J; Schwarz F; Stavropoulos A
    Int J Periodontics Restorative Dent; 2008 Apr; 28(2):153-61. PubMed ID: 18546811
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of EDTA root conditioning on the healing of intrabony defects treated with an enamel matrix protein derivative.
    Sculean A; Berakdar M; Willershausen B; Arweiler NB; Becker J; Schwarz F
    J Periodontol; 2006 Jul; 77(7):1167-72. PubMed ID: 16805678
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of intrabony defects with enamel matrix proteins or barrier membranes: results from a multicenter practice-based clinical trial.
    Sanz M; Tonetti MS; Zabalegui I; Sicilia A; Blanco J; Rebelo H; Rasperini G; Merli M; Cortellini P; Suvan JE
    J Periodontol; 2004 May; 75(5):726-33. PubMed ID: 15212355
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prospective assessment of the use of enamel matrix derivative with minimally invasive surgery: 6-year results.
    Harrel SK; Wilson TG; Nunn ME
    J Periodontol; 2010 Mar; 81(3):435-41. PubMed ID: 20192871
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of intrabony periodontal defects with enamel matrix derivative: a literature review.
    Kalpidis CD; Ruben MP
    J Periodontol; 2002 Nov; 73(11):1360-76. PubMed ID: 12479642
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical evaluation of demineralized freeze-dried bone allograft and enamel matrix derivative versus enamel matrix derivative alone for the treatment of periodontal osseous defects in humans.
    Gurinsky BS; Mills MP; Mellonig JT
    J Periodontol; 2004 Oct; 75(10):1309-18. PubMed ID: 15562907
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Do bone grafts or barrier membranes provide additional treatment effects for infrabony lesions treated with enamel matrix derivatives? A network meta-analysis of randomized-controlled trials.
    Tu YK; Woolston A; Faggion CM
    J Clin Periodontol; 2010 Jan; 37(1):59-79. PubMed ID: 19958442
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peri-implantitis prevalence and treatment in implant-oriented private practices: a cross-sectional postal and Internet survey.
    Schmidlin PR; Sahrmann P; Ramel C; Imfeld T; Müller J; Roos M; Jung RE
    Schweiz Monatsschr Zahnmed; 2012; 122(12):1136-44. PubMed ID: 23239511
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical outcomes after treatment of intra-bony defects with an EMD/synthetic bone graft or EMD alone: a multicentre randomized-controlled clinical trial.
    Jepsen S; Topoll H; Rengers H; Heinz B; Teich M; Hoffmann T; Al-Machot E; Meyle J; Jervøe-Storm PM
    J Clin Periodontol; 2008 May; 35(5):420-8. PubMed ID: 18341601
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A cost-effectiveness evaluation of enamel matrix derivatives alone or in conjunction with regenerative devices in the treatment of periodontal intra-osseous defects.
    Listl S; Tu YK; Faggion CM
    J Clin Periodontol; 2010 Oct; 37(10):920-7. PubMed ID: 20727057
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of intrabony defects with enamel matrix proteins or bioabsorbable membranes. A 4-year follow-up split-mouth study.
    Sculean A; Donos N; Miliauskaite A; Arweiler N; Brecx M
    J Periodontol; 2001 Dec; 72(12):1695-701. PubMed ID: 11811505
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Healing, post-operative morbidity and patient perception of outcomes following regenerative therapy of deep intrabony defects.
    Tonetti MS; Fourmousis I; Suvan J; Cortellini P; Brägger U; Lang NP;
    J Clin Periodontol; 2004 Dec; 31(12):1092-8. PubMed ID: 15560811
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The combined use of Nd:YAG laser and enamel matrix proteins in the treatment of periodontal infrabony defects.
    Dilsiz A; Canakci V; Aydin T
    J Periodontol; 2010 Oct; 81(10):1411-8. PubMed ID: 20528697
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The efficacy of enamel matrix derivative (Emdogain) for the treatment of deep infrabony periodontal defects: a placebo-controlled randomised clinical trial.
    Grusovin MG; Esposito M
    Eur J Oral Implantol; 2009; 2(1):43-54. PubMed ID: 20467617
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autogenous bone graft in conjunction with enamel matrix derivative in the treatment of deep periodontal intra-osseous defects: a report of 13 consecutively treated patients.
    Trombelli L; Annunziata M; Belardo S; Farina R; Scabbia A; Guida L
    J Clin Periodontol; 2006 Jan; 33(1):69-75. PubMed ID: 16367859
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparative study of combined treatment with a collagen membrane and enamel matrix proteins for the regeneration of intraosseous defects.
    Minabe M; Kodama T; Kogou T; Takeuchi K; Fushimi H; Sugiyama T; Mitarai E
    Int J Periodontics Restorative Dent; 2002 Dec; 22(6):595-605. PubMed ID: 12516831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.